81 related articles for article (PubMed ID: 2209919)
1. Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation.
Towler HM; Whiting PH; Forrester JV
Eye (Lond); 1990; 4 ( Pt 3)():514-20. PubMed ID: 2209919
[TBL] [Abstract][Full Text] [Related]
2. Low dose cyclosporin A therapy in chronic posterior uveitis.
Towler HM; Cliffe AM; Whiting PH; Forrester JV
Eye (Lond); 1989; 3 ( Pt 3)():282-7. PubMed ID: 2612672
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of cyclosporin in liver grafting.
Williams R; Blackburn A; Neuberger J; Calne RY
Q J Med; 1985 Dec; 57(224):897-905. PubMed ID: 3912795
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
5. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
6. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.
Clasen W; Kindler J; Mihatsch MJ; Sieberth HG
Nephrol Dial Transplant; 1988; 3(6):733-7. PubMed ID: 3147414
[TBL] [Abstract][Full Text] [Related]
8. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
[TBL] [Abstract][Full Text] [Related]
9. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months.
Bignardi L; Neild GH; Hartley RB; Taube DH; Cameron JS; Rudge CJ; Williams DG; Ogg CS
Nephrol Dial Transplant; 1987; 2(5):366-70. PubMed ID: 3122115
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression by Cyclosporin A in human renal transplant recipients.
Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
[TBL] [Abstract][Full Text] [Related]
11. [Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults].
Koike M; Honda K; Tsukada M; Itabashi M; Suzuki K; Uchida K; Nitta K; Yumura W; Nihei H
Nihon Jinzo Gakkai Shi; 2002; 44(5):447-52. PubMed ID: 12216477
[TBL] [Abstract][Full Text] [Related]
12. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
14. [Plasma levels of cyclosporin 6 hours after its oral administration, T6: key to the surveillance of the treatment].
Cantarovich F; Bizzolon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J
Nephrologie; 1987; 8(3):111-22. PubMed ID: 3658087
[TBL] [Abstract][Full Text] [Related]
15. Treatment of vasculitic IgA nephropathy.
Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[TBL] [Abstract][Full Text] [Related]
16. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
[TBL] [Abstract][Full Text] [Related]
17. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
Carstens J
Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
[TBL] [Abstract][Full Text] [Related]
18. Low dose cyclosporine in rheumatoid arthritis: a pilot study.
Tugwell P; Bombardier C; Gent M; Bennett K; Ludwin D; Grace E; Buchanan WW; Bensen WG; Bellamy N; Murphy GF
J Rheumatol; 1987 Dec; 14(6):1108-14. PubMed ID: 3437417
[TBL] [Abstract][Full Text] [Related]
19. Elective conversion from cyclosporin to azathioprine in living related donor kidney transplants.
Sobh MA; Eldein AB; Moustafa FE; Ghoneim MA
Nephrol Dial Transplant; 1987; 2(4):258-60. PubMed ID: 3118269
[TBL] [Abstract][Full Text] [Related]
20. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
Shin JI; Park JM; Shin YH; Kim JH; Lee JS; Jeong HJ
Scand J Rheumatol; 2005; 34(5):392-5. PubMed ID: 16234188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
